197 related articles for article (PubMed ID: 29627798)
21. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.
Yee D; Novak E; Platts A; Nassif ME; LaRue SJ; Vader JM
Am J Cardiol; 2019 Mar; 123(5):807-812. PubMed ID: 30587373
[TBL] [Abstract][Full Text] [Related]
23. Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.
Tran AT; Fonarow GC; Arnold SV; Jones PG; Thomas LE; Hill CL; DeVore AD; Butler J; Albert NM; Spertus JA
Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e008072. PubMed ID: 34615366
[TBL] [Abstract][Full Text] [Related]
24. Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.
Luo N; O'Connor CM; Cooper LB; Sun JL; Coles A; Reed SD; Whellan DJ; Piña IL; Kraus WE; Mentz RJ
Eur J Heart Fail; 2019 Jan; 21(1):63-70. PubMed ID: 30168635
[TBL] [Abstract][Full Text] [Related]
25. Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials.
Bhatt AS; Kosiborod MN; Vaduganathan M; Claggett BL; Miao ZM; Kulac IJ; Lam CSP; Hernandez AF; Martinez F; Inzucchi SE; Shah SJ; de Boer RA; Jhund PS; Desai AS; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
Eur J Heart Fail; 2023 Jul; 25(7):981-988. PubMed ID: 37211977
[TBL] [Abstract][Full Text] [Related]
26. The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF.
DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Shen X; Hernandez AF; Fonarow GC
Eur J Heart Fail; 2022 May; 24(5):762-770. PubMed ID: 35293088
[TBL] [Abstract][Full Text] [Related]
27. Impact of Telemonitoring on Health Status.
Jayaram NM; Khariton Y; Krumholz HM; Chaudhry SI; Mattera J; Tang F; Herrin J; Hodshon B; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29237746
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial.
Sandhu AT; Calma J; Skye M; Kalwani N; Zheng J; Schirmer J; Din N; Brown Johnson C; Gupta A; Lan R; Yu B; Spertus JA; Heidenreich PA
Circulation; 2024 May; 149(22):1717-1728. PubMed ID: 38583147
[TBL] [Abstract][Full Text] [Related]
29. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
[TBL] [Abstract][Full Text] [Related]
30. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.
Hejjaji V; Tang Y; Coles T; Jones PG; Reeve BB; Mentz RJ; Spatz ES; Dunlay SM; Caldwell B; Saha A; Tarver ME; Tran A; Patel KK; Henke D; Piña IL; Spertus JA
Circ Heart Fail; 2021 Sep; 14(9):e008284. PubMed ID: 34465123
[TBL] [Abstract][Full Text] [Related]
31. Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction.
Butler J; Khan MS; Mori C; Filippatos GS; Ponikowski P; Comin-Colet J; Roubert B; Spertus JA; Anker SD
Eur J Heart Fail; 2020 Jun; 22(6):999-1005. PubMed ID: 32239794
[TBL] [Abstract][Full Text] [Related]
32. Health status identifies heart failure outpatients at risk for hospitalization or death.
Heidenreich PA; Spertus JA; Jones PG; Weintraub WS; Rumsfeld JS; Rathore SS; Peterson ED; Masoudi FA; Krumholz HM; Havranek EP; Conard MW; Williams RE;
J Am Coll Cardiol; 2006 Feb; 47(4):752-6. PubMed ID: 16487840
[TBL] [Abstract][Full Text] [Related]
33. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
Kosiborod MN; Angermann CE; Collins SP; Teerlink JR; Ponikowski P; Biegus J; Comin-Colet J; Ferreira JP; Mentz RJ; Nassif ME; Psotka MA; Tromp J; Brueckmann M; Blatchford JP; Salsali A; Voors AA
Circulation; 2022 Jul; 146(4):279-288. PubMed ID: 35377706
[TBL] [Abstract][Full Text] [Related]
34. Health-Related Quality of Life Outcomes in PARADIGM-HF.
Lewis EF; Claggett BL; McMurray JJV; Packer M; Lefkowitz MP; Rouleau JL; Liu J; Shi VC; Zile MR; Desai AS; Solomon SD; Swedberg K
Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784687
[TBL] [Abstract][Full Text] [Related]
35. Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
Hejjaji V; Cohen DJ; Carroll JD; Li Z; Manandhar P; Vemulapalli S; Nelson AJ; Malik AO; Mack MJ; Spertus JA; Arnold SV
Circ Cardiovasc Qual Outcomes; 2021 Mar; 14(3):e007187. PubMed ID: 33596663
[TBL] [Abstract][Full Text] [Related]
36. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure.
Rumsfeld JS; Havranek E; Masoudi FA; Peterson ED; Jones P; Tooley JF; Krumholz HM; Spertus JA;
J Am Coll Cardiol; 2003 Nov; 42(10):1811-7. PubMed ID: 14642693
[TBL] [Abstract][Full Text] [Related]
37. Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure.
Flynn KE; Lin L; Ellis SJ; Russell SD; Spertus JA; Whellan DJ; Piña IL; Fine LJ; Schulman KA; Weinfurt KP;
Am Heart J; 2009 Oct; 158(4 Suppl):S64-71. PubMed ID: 19782791
[TBL] [Abstract][Full Text] [Related]
38. Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.
Butler J; Stebbins A; Melenovský V; Sweitzer NK; Cowie MR; Stehlik J; Khan MS; Blaustein RO; Ezekowitz JA; Hernandez AF; Lam CSP; Nkulikiyinka R; O'Connor CM; Pieske BM; Ponikowski P; Spertus JA; Voors AA; Anstrom KJ; Armstrong PW;
Circ Heart Fail; 2022 Jun; 15(6):e009337. PubMed ID: 35656822
[TBL] [Abstract][Full Text] [Related]
39. Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
Kosiborod MN; Bhatt AS; Claggett BL; Vaduganathan M; Kulac IJ; Lam CSP; Hernandez AF; Martinez FA; Inzucchi SE; Shah SJ; de Boer RA; Jhund PS; Desai AS; Fang JC; Han Y; Comin-Colet J; Vardeny O; Lindholm D; Wilderäng U; Bengtsson O; McMurray JJV; Solomon SD
J Am Coll Cardiol; 2023 Feb; 81(5):460-473. PubMed ID: 36526515
[TBL] [Abstract][Full Text] [Related]
40. Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
Circ Heart Fail; 2020 Jul; 13(7):e006833. PubMed ID: 32580657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
